{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~58 mi. (Columbia, Missouri, +523 more cities)
facility
University of Missouri - Ellis Fischel
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
city
~58 mi. (Columbia, Missouri, +233 more cities)
facility
University of Missouri - Ellis Fischel
drug
degarelix, +4 more drugs
drug type
hormone therapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~58 mi. (Columbia, Missouri, +825 more cities)
facility
University of Missouri - Ellis Fischel
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
city
~58 mi. (Columbia, Missouri, +235 more cities)
facility
University of Missouri - Ellis Fischel
drug
abiraterone, +9 more drugs
drug type
hormone therapy, +2 more types
Comparing the New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
city
~58 mi. (Columbia, Missouri, +215 more cities)
facility
University of Missouri - Ellis Fischel
drug
eribulin, +1 more drug